nVerses Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,400
Closed -$392K 560
2024
Q3
$392K Buy
+3,400
New +$392K 0.18% 177